Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
3.
ACS Appl Mater Interfaces ; 11(9): 9251-9258, 2019 Mar 06.
Artigo em Inglês | MEDLINE | ID: mdl-30746929

RESUMO

The insufficient electron injection constitutes the major obstacle to achieving high-performance inverted organic light-emitting diodes (OLEDs). Here, a facile electron-injection architecture featuring a silver nanoparticle (AgNPs) interlayer-modified sol-gel-derived transparent zinc oxide (ZnO) ultrathin film is proposed and demonstrated. The optimized external quantum efficiencies of the developed inverted fluorescent and phosphorescent OLEDs capitalized on our proposed electron-injection structure reached 4.0 and 21.2% at a current density of 20 mA cm-2 and increased by a factor of 1.90 and 2.86 relative to a reference device without the AgNP interlayer, while simultaneously reducing the operational voltage and substantially ameliorating the device efficiency. Detailed analyses reveal that the local surface plasmon resonance emanated from AgNPs plays three meaningful roles simultaneously: suppressing the surface plasmon polariton mode loss, aiding in energy-level alignments, and inducing and reinforcing the local exciton-plasmon coupling electric field. Among these interesting and multifunctional roles, the enhanced local exciton-plasmon coupling electric field dominates the electron injection enhancement and substantial increases the device efficiency. Additionally, the light-scattering effect also helps in recovering the trapped light energy flux and thus improves the device efficiency. The proposed approach and findings provide an alternative path to fabricate high-performance inverted OLEDs and other related organic electronic or optoelectronic devices.

4.
Acta Pharmacol Sin ; 39(12): 1894-1901, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30297804

RESUMO

Although the treatment of adult T-cell acute lymphoblastic leukemia (T-ALL) has been significantly improved, the heterogeneous genetic landscape of the disease often causes relapse. Aberrant activation of mammalian target of rapamycin (mTOR) pathway in T-ALL is responsible for treatment failure and relapse, suggesting that mTOR inhibition may represents a new therapeutic strategy. In this study, we investigated whether the mTOR complex 1 (mTORC1) inhibitor everolimus could be used as a therapeutic agent against human T-ALL. We showed that rapamycin and its analog RAD001 (everolimus) exerted only mild inhibition on the viability of Jurkat, CEM and Molt-4 cell lines (for everolimus the maximum inhibition was <40% at 100 nM), but greatly enhanced the phosphorylation of eIF4E, a downstream substrate of MAPK-interacting kinase (MNK) that was involved in promoting cell survival. Furthermore, we demonstrated in Jurkat cells that mTOR inhibitor-induced eIF4E phosphorylation was independent of insulin-like growth factor-1/insulin-like growth factor-1 receptor axis, but was secondary to mTOR inhibition. Then we examined the antileukemia effects of CGP57380, a MNK1 inhibitor, and we found that CGP57380 (4-16 µM) dose-dependently suppressed the expression of both phosphor-MNK1 and phosphor-eIF4E, thereby inhibiting downstream targets such as c-Myc and survivin in T-ALL cells. Importantly, CGP57380 produced a synergistic growth inhibitory effect with everolimus in T-ALL cells, and treatment with this targeted therapy overcame everolimus-induced eIF4E phosphorylation. In conclusion, our results suggest that dual-targeting of mTOR and MNK1/eIF4E signaling pathways may represent a novel therapeutic strategy for the treatment of human T-ALL.


Assuntos
Compostos de Anilina/farmacologia , Antineoplásicos/farmacologia , Fator de Iniciação 4E em Eucariotos/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular/antagonistas & inibidores , Leucemia-Linfoma Linfoblástico de Células T Precursoras/tratamento farmacológico , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Purinas/farmacologia , Linhagem Celular Tumoral , Sinergismo Farmacológico , Everolimo/farmacologia , Humanos , Alvo Mecanístico do Complexo 1 de Rapamicina/antagonistas & inibidores , Fosforilação/efeitos dos fármacos , Sirolimo/farmacologia
5.
Yi Chuan ; 34(5): 615-20, 2012 May.
Artigo em Chinês | MEDLINE | ID: mdl-22659434

RESUMO

The mutant of "Sanming Dominant Genic Male Sterile Rice" was found from an F2 population of cross "SE2lS/Basmati370" by Sanming Institute of Agricultural Science in 2001. It has proven that the male sterility of this mutant is controlled by a dominant gene (named as SMS). By multiple backcrosses, this dominant male sterile allele was introduced into the genetic background of an indica rice cultivar Jiafuzhan (which was known as Jiabuyu). In order to map SMS, a mapping population was constructed by crossing Jiabuyu with a japonica cultivar Nipponbare and further crossing the F1 with Jiafuzhan. By bulked segregant analysis and linkage analysis using SSR and INDEL markers, SMS was mapped to a 99 kb interval between INDEL markers ZM30 and ZM9 on chromosome 8. This result will facilitate cloning of SMS.


Assuntos
Mapeamento Cromossômico , Oryza/genética , Infertilidade das Plantas/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA